242 related articles for article (PubMed ID: 21454093)
1. Body mass index and the risk of progression of chronic kidney disease.
Khedr A; Khedr E; House AA
J Ren Nutr; 2011 Nov; 21(6):455-61. PubMed ID: 21454093
[TBL] [Abstract][Full Text] [Related]
2. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
3. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
[TBL] [Abstract][Full Text] [Related]
4. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.
Lo JC; Go AS; Chandra M; Fan D; Kaysen GA
Am J Kidney Dis; 2007 Oct; 50(4):552-8. PubMed ID: 17900454
[TBL] [Abstract][Full Text] [Related]
5. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
6. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
[TBL] [Abstract][Full Text] [Related]
7. Association of body mass index with decline in residual kidney function after initiation of dialysis.
Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
[TBL] [Abstract][Full Text] [Related]
8. Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.
Garland JS; Holden RM; Hopman WM; Gill SS; Nolan RL; Morton AR
J Ren Nutr; 2013 Jan; 23(1):4-11. PubMed ID: 22542819
[TBL] [Abstract][Full Text] [Related]
9. Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects.
Brown RN; Mohsen A; Green D; Hoefield RA; Summers LK; Middleton RJ; O'Donoghue DJ; Kalra PA; New DI
Nephrol Dial Transplant; 2012 Jul; 27(7):2776-80. PubMed ID: 22442391
[TBL] [Abstract][Full Text] [Related]
10. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
11. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
12. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
13. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
14. Bariatric surgery and progression of chronic kidney disease.
Navaneethan SD; Yehnert H
Surg Obes Relat Dis; 2009; 5(6):662-5. PubMed ID: 19359221
[TBL] [Abstract][Full Text] [Related]
15. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
16. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
Bianchi ME; Farías EF; Bolaño J; Massari PU
Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure and progression of chronic kidney disease.
Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
[TBL] [Abstract][Full Text] [Related]
19. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study.
Carvalho LK; Barreto Silva MI; da Silva Vale B; Bregman R; Martucci RB; Carrero JJ; Avesani CM
Nephrol Dial Transplant; 2012 Apr; 27(4):1423-8. PubMed ID: 21825305
[TBL] [Abstract][Full Text] [Related]
20. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease.
Sengstock D; Sands RL; Gillespie BW; Zhang X; Kiser M; Eisele G; Vaitkevicius P; Kuhlmann M; Levin NW; Hinderliter A; Rajagopalan S; Saran R
Nephrol Dial Transplant; 2010 Mar; 25(3):853-61. PubMed ID: 19854848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
